Wadhwa D, Monga A, Kumar N, Khullar G, Karmakar S, Khunger N
Dermatol Pract Concept. 2023; 13(4).
PMID: 37992388
PMC: 10656157.
DOI: 10.5826/dpc.1304a263.
Inamadar A
Indian Dermatol Online J. 2022; 13(4):445-448.
PMID: 36262583
PMC: 9574152.
DOI: 10.4103/idoj.idoj_139_22.
Czech T, Sugihara S, Nishimura Y
J Cosmet Dermatol. 2022; 21(9):3655-3662.
PMID: 35801366
PMC: 9349634.
DOI: 10.1111/jocd.15218.
Aryanian Z, Balighi K, Hatami P, Mohseni Afshar Z, Mohandesi N
Dermatol Ther. 2022; 35(6):e15433.
PMID: 35266262
PMC: 9111640.
DOI: 10.1111/dth.15433.
Otsuka Y, Nakano Y, Hagiya H, Tokumasu K, Otsuka F
Cureus. 2022; 14(1):e21160.
PMID: 35165610
PMC: 8831424.
DOI: 10.7759/cureus.21160.
COVID-19 and Its Repercussions on Oral Health: A Review.
Rusu L, Ardelean L, Tigmeanu C, Matichescu A, Sauciur I, Bratu E
Medicina (Kaunas). 2021; 57(11).
PMID: 34833407
PMC: 8619825.
DOI: 10.3390/medicina57111189.
Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
Babaei K, Kavoussi H, Rezaei M, Kavoussi R
An Bras Dermatol. 2021; 96(6):688-692.
PMID: 34593265
PMC: 8440166.
DOI: 10.1016/j.abd.2021.05.006.
Clinical Patterns and Morphology of COVID-19 Dermatology.
Agnihothri R, Fox L
Dermatol Clin. 2021; 39(4):487-503.
PMID: 34556240
PMC: 8165088.
DOI: 10.1016/j.det.2021.05.006.
Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.
Rossi A, Magri F, Sernicola A, Michelini S, Caro G, Muscianese M
Skin Appendage Disord. 2021; 21:1-5.
PMID: 34373830
PMC: 8339054.
DOI: 10.1159/000517223.
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
Starace M, Iorizzo M, Sechi A, Alessandrini A, Carpanese M, Bruni F
JAAD Int. 2021; 5:11-18.
PMID: 34368790
PMC: 8328568.
DOI: 10.1016/j.jdin.2021.07.006.
Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations.
Thuangtong R, Angkasekwinai N, Leeyaphan C, Triwongwaranat D, Thanomkitti K, Munprom K
Biomed Res Int. 2021; 2021:5595016.
PMID: 34258268
PMC: 8238562.
DOI: 10.1155/2021/5595016.
Telogen effluvium in the new SARS-CoV-2 era.
Ocampo-Garza S, Vastarella M, Nappa P, Cantelli M, Fabbrocini G
Int J Dermatol. 2021; 60(7):e265-e266.
PMID: 33660272
PMC: 8014532.
DOI: 10.1111/ijd.15482.
Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence.
Rinaldi F, Trink A, Giuliani G, Pinto D
Dermatol Ther (Heidelb). 2021; 11(2):339-345.
PMID: 33580408
PMC: 7880634.
DOI: 10.1007/s13555-021-00498-9.
Telogen effluvium associated with COVID-19 infection.
Olds H, Liu J, Luk K, Lim H, Ozog D, Rambhatla P
Dermatol Ther. 2021; 34(2):e14761.
PMID: 33405302
PMC: 7883200.
DOI: 10.1111/dth.14761.
Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019.
Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K
Open Forum Infect Dis. 2020; 7(11):ofaa507.
PMID: 33230486
PMC: 7665672.
DOI: 10.1093/ofid/ofaa507.
